Company Filing History:
Years Active: 2017
Title: **Jan Krummenacker: Innovator in Hyperpolarization Technology**
Introduction
Jan Krummenacker is an accomplished inventor based in Beckingen, Germany, known for his contribution to the field of magnetic resonance imaging (MRI). His innovative approach focuses on the hyperpolarization of contrast agents, enhancing the effectiveness of MRI technology for medical applications.
Latest Patents
Krummenacker holds a significant patent titled "Hyperpolarization apparatus and method for administration of a hyperpolarized liquid contrast agent." This patent outlines a novel method where a hyperpolarized liquid contrast agent is administered via a specific conduit in a microwave (MW) resonator. The design utilizes a microwave frequency of at least 40 GHz to polarize the liquid contrast agent as it passes through the MW resonator, employed in conjunction with dynamic nuclear polarization (DNP). This cutting-edge technique allows for the immediate administration of the polarized contrast agent, significantly improving imaging results within MRI devices.
Career Highlights
Jan Krummenacker is affiliated with the Johann Wolfgang Goethe University Frankfurt am Main, where he has made remarkable strides in the research and development of advanced imaging technologies. His work centers around the intersection of physics and medical technology, emphasizing the importance of enhancing MRI imaging through innovative contrast agents.
Collaborations
Throughout his career, Krummenacker has worked alongside esteemed colleagues such as Thomas Prisner and Vasyl Denysenkov. Their collective expertise has fostered an environment of innovation, allowing them to push the boundaries of MRI technology and its practical applications in healthcare.
Conclusion
Jan Krummenacker's contributions to the field of hyperpolarization technology exemplify the transformative potential of innovation in medical imaging. With a strong foundation in research and collaborative endeavors, he continues to pave the way for advancements that can revolutionize MRI diagnostics and patient care.